Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers
1 clinical trials · Condition
◉ Watch Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers
| Record | Firm | Date |
|---|---|---|
| PARP-inhibitor on Advanced Metastatic Breast Cancer in Germline PALB2 Mutations Carriers (NCT05232006) | Assistance Publique - Hôpitaux de Paris | 2022-05-01 |
Track Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers automatically
Every clearance here is in the API, with alerts when new ones post.